Reports

• Publish Date: May-2022
• Report Code: QI042
• Price: $ 1800/-

Asia-Pacific is a rapidly growing cancer market. The market is forecasted to grow at a compound annual growth rate (CAGR) of 17.3% resulting in annual revenue of USD 32.26 Bn during the forecast period (2018-2023). Asia Pacific is rapidly adopting the latest technological developments and is contributing towards exhaustive research...

• Publish Date: May-2022
• Report Code: QI042
• Price: $ 1800/-

Chinas demand for cancer screening has grown at a fast pace in the past decade. Cancer is one of the most significant healthcare burdens in China. The Chinese economy maintains a high pace of growth stimulated by the consecutive increase in capital investment. The cancer screening market in China is...

• Publish Date: May-2022
• Report Code: QI042
• Price: $ 1800/-

The United Kingdom (U.K.) stands next to the United States of America (U.S.A.) in coming up with latest technologies to combat the spread of cancer. The cancer screening market in the U.K. is expected to reach USD Bn by 2023 at a CAGR of 8.5%. Cancer screening market in the...

• Publish Date: May-2022
• Report Code: QI042
• Price: $ 1800/-

The United States Of America (U.S.A.) is leading the cancer screening market. The rising incidence of cancer along with growing awareness regarding prevention of diseases and diagnosis is a key driver for the market. There is increased technological advancement along with fund based initiatives towards research and development (R&D) for...